fbpx

Science

Study Title
Host Responses to Intestinal Microbial Antigens in Gluten-Sensitive Mice
Publication
PLOS One
Author(s)

Jane M. Natividad, Xianxi Huang, Emma Slack, Jennifer Jury, Yolanda Sanz, Chella David,
Emmanuel Denou, Pinchang Yang, Joseph Murray, Kathy D. McCoy, Elena F. Verdu ́

Abstract

Background and Aims:
Excessive uptake of commensal bacterial antigens through a permeable intestinal barrier may influence host responses to specific antigen in a genetically predisposed host. The aim of this study was to investigate whether intestinal barrier dysfunction induced by indomethacin treatment affects the host response to intestinal microbiota in gluten-sensitized HLA-DQ8/HCD4 mice.
Methodology/Principal Findings:
HLA-DQ8/HCD4 mice were sensitized with gluten, and gavaged with indomethacin plus gluten. Intestinal permeability was assessed by Ussing chamber; epithelial cell (EC) ultra-structure by electron microscopy; RNA expression of genes coding for junctional proteins by Q-real-time PCR; immune response by in-vitro antigen-specific T- cell proliferation and cytokine analysis by cytometric bead array; intestinal microbiota by fluorescence in situ hybridization and analysis of systemic antibodies against intestinal microbiota by surface staining of live bacteria with serum followed by FACS analysis. Indomethacin led to a more pronounced increase in intestinal permeability in gluten-sensitized mice. These changes were accompanied by severe EC damage, decreased E-cadherin RNA level, elevated IFN-c in splenocyte culture supernatant, and production of significant IgM antibody against intestinal microbiota.
Conclusion:
Indomethacin potentiates barrier dysfunction and EC injury induced by gluten, affects systemic IFN-c production and the host response to intestinal microbiota antigens in HLA-DQ8/HCD4 mice. The results suggest that environmental factors that alter the intestinal barrier may predispose individuals to an increased susceptibility to gluten through a bystander immune activation to intestinal microbiota.

Date
July 31, 2009
View study

Share This

Related Topics

GlutenCeliac Disease

Dr. Perlmutter is one of the leading lights in medicine today, illuminating the path for solving chronic illness

Mark Hyman, MD